Nicoline Hoogerbrugge

发表

Risks of less common cancers in proven mutation carriers with lynch syndrome.

Markus Loeffler, Christoph Engel, Magnus von Knebel Doeberitz, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bmc Cancer

Leila Mohammadi, Peter Devilee, Hans C van Houwelingen, 2022 .

Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.

Iris Lansdorp-Vogelaar, Petur Snaebjornsson, I. Lansdorp-Vogelaar, 2017, Gastrointestinal endoscopy.

Germline copy number variation and cancer risk.

R. Kuiper, M. Ligtenberg, N. Hoogerbrugge, 2010, Current opinion in genetics & development.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Joshua M. Korn, Christiana Kartsonaki, Amanda B. Spurdle, 2010, PLoS Genetics.

Body weight and risk of breast cancer in BRCA1/2 mutation carriers

Maartje J. Hooning, H. Meijers-Heijboer, M. Hooning, 2011, Breast Cancer Research and Treatment.

Identification of candidate predisposing copy number variants in familial and early‐onset colorectal cancer patients

A. V. van Kessel, R. Kuiper, H. Schackert, 2011, International journal of cancer.

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Harry J de Koning, Madeleine M A Tilanus-Linthorst, Mieke Kriege, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BMC Cancer

Leila Mohammadi, Peter Devilee, H. V. van Houwelingen, 2001 .

Familial Breast Cancer: Detection of Prevalent High-Risk Epithelial Lesions

Peter Bult, P. Bult, N. Hoogerbrugge, 2008 .

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

Suet Yi Leung, Han G Brunner, Tsun Leung Chan, 2009, Nature Genetics.

Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study

Douglas F. Easton, Antonis C. Antoniou, Ana Osorio, 2007, Cancer Epidemiology Biomarkers & Prevention.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

NTHL1 defines novel cancer syndrome

R. Kuiper, N. Hoogerbrugge, Nicoline Hoogerbrugge, 2015, Oncotarget.

Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.

A. Wagner, M. Ausems, P. Manders, 2015, Gastroenterology.

A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting

H. Meijers-Heijboer, S. Verhoef, R. Hofstra, 2006, Human mutation.

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation

L. Kiemeney, A. V. van Kessel, R. Kuiper, 2011, European Journal of Human Genetics.